Monte Rosa Therapeutics

Monte Rosa Therapeutics

  • Founded: 2018
  • Location: Basel , Switzerland
  • Employee range: 11 - 50
  • Clinical stage: Clin1/Clin2
  • Therapy area: Multiple cancers
  • Drug types: ONC, IMM, GEN, HEM
  • Lead product: MRT-2359
  • Product link:
  • Funding: $223M IPO Jun 2021; $95M C Mar 2021; $96M B Sep 2020; $32.5M May 2020
  • Investors: Versant Ventures

job board

Short description:

Small molecule cancer drugs that modulate protein degradation pathways

Drug notes:

Undisclosed Clin0 autoimmune disease; 4 undisclosed programs RD inflammatory diseases, multiple cancers, sickle cell disease, B-thalassemia, undisclosed

Long description:

Contact us to add description.


© 2023 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy